Influence of betaxolol and timolol on the visual fields of patients with glaucoma
- PMID: 1957903
- DOI: 10.1016/s0002-9394(14)77274-5
Influence of betaxolol and timolol on the visual fields of patients with glaucoma
Abstract
In a double-masked study, 40 patients with primary open-angle glaucoma were randomly assigned to treatment with betaxolol 0.5% or timolol 0.5% in both eyes twice daily. Visual fields and intraocular pressures were studied. Perimetry was performed with the Octopus G1 program two weeks after a washout period and three, six, 12, and 18 months after initiation of treatment. Both drugs reduced intraocular pressure. The reduction in intraocular pressure in the timolol-treated group was more pronounced than that in the betaxolol-treated group; the difference, however, was not statistically significant. In both treatment groups, the visual fields tended to improve during the first six months of treatment and remained stable or tended to deteriorate thereafter. The treatment effect on the visual field was better in the betaxolol-treated group than it was in the timolol-treated group (P = .041).
Similar articles
-
Longterm effect of topical beta-blockers on intraocular pressure and visual field sensitivity in ocular hypertension and chronic open-angle glaucoma.Surv Ophthalmol. 1994 May;38 Suppl:S149-55. doi: 10.1016/0039-6257(94)90059-0. Surv Ophthalmol. 1994. PMID: 7940136 Clinical Trial.
-
The favorable effect of topical betaxolol and timolol on glaucomatous visual fields: a 2-year follow-up study.Graefes Arch Clin Exp Ophthalmol. 1999 Feb;237(2):100-4. doi: 10.1007/s004170050202. Graefes Arch Clin Exp Ophthalmol. 1999. PMID: 9987624 Clinical Trial.
-
Longterm visual field follow-up of glaucoma patients treated with beta-blockers.Surv Ophthalmol. 1994 May;38 Suppl:S156-9; discussion S160. doi: 10.1016/0039-6257(94)90060-4. Surv Ophthalmol. 1994. PMID: 7940137 Clinical Trial.
-
Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.Prog Retin Eye Res. 2010 Jan;29(1):79-93. doi: 10.1016/j.preteyeres.2009.08.002. Epub 2009 Sep 4. Prog Retin Eye Res. 2010. PMID: 19733652 Review.
-
Comparison of ophthalmic beta-blocking agents.Clin Pharm. 1987 Jun;6(6):451-63. Clin Pharm. 1987. PMID: 2891463 Review.
Cited by
-
Influence of betaxolol and timolol on the venous tone in glaucoma patients.Int Ophthalmol. 1999;23(3):149-53. doi: 10.1023/a:1010683130919. Int Ophthalmol. 1999. PMID: 11456252 Clinical Trial.
-
Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.Br J Ophthalmol. 2005 Apr;89(4):504-7. doi: 10.1136/bjo.2004.052860. Br J Ophthalmol. 2005. PMID: 15774933 Free PMC article.
-
Pharmacological neuroprotection for glaucoma.Drugs. 2007;67(5):725-59. doi: 10.2165/00003495-200767050-00006. Drugs. 2007. PMID: 17385943 Review.
-
Effects of timolol on visual-field mean retinal sensitivity in normal subjects.Int Ophthalmol. 1992 Sep;16(4-5):325-9. doi: 10.1007/BF00917985. Int Ophthalmol. 1992. PMID: 1428567 Clinical Trial.
-
Topical drug therapy in glaucoma.Wien Med Wochenschr. 2006 Sep;156(17-18):501-7. doi: 10.1007/s10354-006-0335-0. Wien Med Wochenschr. 2006. PMID: 17041807 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical